FLOZIMIA Trademark

Trademark Overview

On Friday, December 3, 2021, a trademark application was filed for FLOZIMIA with the United States Patent and Trademark Office. The USPTO has given the FLOZIMIA trademark a serial number of 97155394. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Friday, June 28, 2024. This trademark is owned by Chiesi USA, Inc.. The FLOZIMIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical compositions for catheter clearance, namely, thrombolytics enzymes
flozimia

General Information

Serial Number97155394
Word MarkFLOZIMIA
Filing DateFriday, December 3, 2021
Status731 - SECOND EXTENSION - GRANTED
Status DateFriday, June 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 9, 2023

Trademark Statements

Goods and ServicesPharmaceutical compositions for catheter clearance, namely, thrombolytics enzymes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 28, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameChiesi USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCary, NC 27518
Party NameChiesi USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCary, NC 27518

Trademark Events

Event DateEvent Description
Tuesday, September 20, 2022NOTIFICATION OF PRIORITY ACTION E-MAILED
Tuesday, December 7, 2021NEW APPLICATION ENTERED
Tuesday, December 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 13, 2022ASSIGNED TO EXAMINER
Tuesday, September 20, 2022PRIORITY ACTION WRITTEN
Tuesday, September 20, 2022PRIORITY ACTION E-MAILED
Tuesday, March 7, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 7, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 8, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 28, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 28, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, March 28, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 28, 2023EXAMINER'S AMENDMENT ENTERED
Monday, April 3, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 19, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 9, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 9, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 4, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 5, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 5, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 5, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 5, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, January 4, 2024SOU EXTENSION 1 FILED
Thursday, January 4, 2024SOU TEAS EXTENSION RECEIVED
Thursday, January 4, 2024SOU EXTENSION 1 GRANTED
Friday, June 28, 2024SOU TEAS EXTENSION RECEIVED
Friday, June 28, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 28, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 28, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 28, 2024SOU EXTENSION 2 FILED
Friday, June 28, 2024SOU EXTENSION 2 GRANTED
Saturday, January 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

flozimia thrombolytics enzymes namely clearance compositions catheter pharmaceutical